Source - SMW
Liberum Capital today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price target at 1900p.

Related Charts

GlaxoSmithKline (GSK)

-6.75p (-0.43%)
delayed 18:15PM